您好, 歡迎來(lái)到制藥網(wǎng)! 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置:杭州昊鑫生物科技股份有限公司>>MCE>>生物試劑>> HY-B0215Acetylcysteine試劑
HY-B0215
MCE
代理商
杭州市
500 mg 400元 10000可售
5 g 500元 10000可售
10 g 600元 10000可售
聯(lián)系方式:鄧女士查看聯(lián)系方式
更新時(shí)間:2023-05-25 15:19:34瀏覽次數(shù):400次
聯(lián)系我時(shí),請(qǐng)告知來(lái)自 制藥網(wǎng)產(chǎn)地 | 進(jìn)口 | 級(jí)別 | 其他 |
---|
Acetylcysteine試劑生物活性
NAC(防治)是一種黏液溶解的代理,減少粘液的厚度。NAC是一種活性氧抑制劑[1]。乙酰半cystine是一種半cystine前體,防止hemin-induced ferroptosis通過(guò)中和生成有毒的脂質(zhì)arachidonate-dependent 5-lipoxygenases活動(dòng)[5]。NAC誘發(fā)細(xì)胞凋亡[2][3]。NAC還具有抗流感病毒活動(dòng)
Acetylcysteine試劑IC50 & Target
Human Endogenous Metabolite
體外研究 (In Vitro) | Acetylcysteine prevents apoptotic DNA fragmentation and maintains long-term survival in the absence of other trophic support in serum-deprived PC12 cells. Acetylcysteine also prevents death of PC12 cells and sympathetic neurons[2]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
體內(nèi)研究 (In Vivo) | Acetylcysteine (150, 300 mg/kg) treatment significantly reduces liver transaminases in all groups of treatment, mostly in group Acetylcysteine 300. Lung glutathione peroxidase is significantly increases in group Acetylcysteine 300 (P=0.04), while the other oxidation biomarkers show no significant differences[6]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
分子量 | 163.19 | ||||||||||||||||
性狀 | Solid | ||||||||||||||||
Formula | C5H9NO3S | ||||||||||||||||
CAS 號(hào) | 616-91-1 | ||||||||||||||||
中文名稱 | |||||||||||||||||
結(jié)構(gòu)分類 |
| ||||||||||||||||
運(yùn)輸條件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
儲(chǔ)存方式 | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) | ||||||||||||||||
溶解性數(shù)據(jù) | In Vitro: H2O : 163 mg/mL (998.84 mM; ultrasonic and adjust pH to 7 with NaOH) DMSO : ≥ 100 mg/mL (612.78 mM) * "≥" means soluble, but saturation unknown. 配制儲(chǔ)備液
* 請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。 In Vivo: 請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥方式選擇適當(dāng)?shù)娜芙夥桨?。以下溶解方案都?qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑: ——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
|
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),制藥網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購(gòu)買風(fēng)險(xiǎn),建議您在購(gòu)買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。